Inherited mutations in the BRCA1 and BRCA2 genes are linked to a high lifetime risk of breast and other cancers. The reviewed study shows that women who know that they have a BRCA mutation before they are diagnosed with breast cancer have improved outcomes including diagnosis at earlier stages and improved overall survival. This article was prepared by XRAY, a publication that provides reliable information about cancer research-related news and information.
Read more: https://www.facingourrisk.org/XRAY/better-outcomes-for-women-that-know-BRCA-mutation-status
Today marks the launch of The Screen Project Phase II! The Screen Project is a Canadian National initiative to make BRCA1 & BRCA2 screening available to all Canadians over 18 years of age at an accessible price. As part of The Screen Project, you will also help their team of researchers at the Familial Breast Cancer Research Unit of Women’s College Hospital evaluate the benefits of population-based genetic testing. The hope that is that this study will reduce the mortality from breast, ovarian, prostate and other cancers.
The Screen Project provides accessible testing to high quality, timely and affordable genetic testing to all Canadians, regardless of family history of cancer. The testing costs $250 and is conducted by Invitae, a reputable lab based in the United States, which is significantly more affordable than comparable genetic testing services. You also have the benefit of knowing that your results will help inform the future of genetic testing in Canada.
We hope that this great project will act as a resource to the members of our BC Ashkenazi Jewish community who are interested in genetic testing but may not currently qualify for BC’s Hereditary Cancer Program.
For more details, please check out The Screen Project’s updated website: www.thescreenproject.ca.